RemedyMeds · individual offer review

Semaglutide treatment option.

The public site names this treatment option, but no current dollar quote was exposed in the reviewed page.

Read the receipt.

Displayed amount
Quote required Current quote required
Delivery route
Confirm route
Product status
Formulation to confirm
Membership in this figure
See provider inclusions and terms
Quantity
Confirm the exact supplied quantity
Upfront commitment
Confirm the initial charge and billing period

Confirm consultation, labs, shipping, supplies, cancellation and the complete initial invoice. Unspecified charges are not assumed to be zero.

Sources: RemedyMeds — treatment selection, RemedyMeds — terms of service, FDA — concerns with unapproved GLP-1 drugs

What this price means.

A selected intake quote should identify the exact preparation, route, supply, included clinical support, billing interval and cancellation policy. Historical advertised prices are not substituted for current terms. A conditional guarantee should be checked against the service agreement before enrollment.

Sources: RemedyMeds — treatment selection, RemedyMeds — terms of service, FDA — concerns with unapproved GLP-1 drugs

The product context.

Wegovy is an FDA-approved semaglutide medicine with formulation-specific labeling. Compounded semaglutide is not FDA-approved and is not a generic version of Wegovy. A provider’s starting price may apply to a particular strength or commitment. None of the prices here establishes that a preparation is appropriate or legally available for a particular patient.

Sources: Wegovy — prescribing information, FDA — compounding questions and answers, FDA — concerns with unapproved GLP-1 drugs

Before you pay.

What will actually be charged today?

Confirm the initial charge and billing period. Request the full amount due today, its supply period, the next charge date and the renewal amount. The displayed price is a sourced offer, not a personalized invoice.

Is this a clinical recommendation?

No. This review covers public product and price information. Eligibility, treatment choice and the prescribed amount require an appropriate clinician. We have not tested this product.

What should I compare it with?

Start with the same ingredient, route, supplied quantity and billing term. Add any separate care or membership fees. Differences in product approval or formulation remain meaningful even when prices are similar.

Follow the evidence

Sources & price notes

Each source retains its own check date. Provider pages document advertised terms; they do not independently establish clinical outcomes.

  1. RemedyMeds — treatment selection ↗

    The public page offers semaglutide and tirzepatide options but did not expose a current dollar quote. Historical $299/$399 figures were not reused.

    Checked October 9, 2026

  2. RemedyMeds — terms of service ↗

    Terms apply to subscriptions, clinical services and any conditional guarantee. Marketing language does not establish an unconditional refund.

    Checked October 9, 2026

  3. FDA — concerns with unapproved GLP-1 drugs ↗

    Safety, dosing errors, salt forms and misleading online marketing. Regulatory page rechecked October 9, 2026; retain distinctions between approval, risk information and compounding nominations.

    Checked October 9, 2026

  4. Wegovy — prescribing information ↗

    Formulation-specific approved uses, contraindications and warnings.

    Checked October 8, 2026

  5. FDA — compounding questions and answers ↗

    Clinical and regulatory context. A compounded preparation is not FDA-approved.

    Checked October 8, 2026